Viewing Study NCT02244294


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-03-02 @ 3:43 PM
Study NCT ID: NCT02244294
Status: COMPLETED
Last Update Posted: 2014-09-19
First Post: 2014-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 527.26
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators